MEGHAN ELSHOFF: Open Payments
NPI 1306412044 · TROY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 42 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $964
Food & beverage: $806Education: $158
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $205 |
| PFIZER INC. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Celgene Corporation | 3 | $61 |
| EMD Serono, Inc. | 2 | $49 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Eisai Inc. | 2 | $42 |
| TerSera Therapeutics LLC | 2 | $38 |
| Stemline Therapeutics Inc. | 2 | $34 |
Products named: DARZALEX, ERLEADA, clonoSEQ, Lenvima, TECVAYLI, REBLOZYL, IBRANCE, IMFINZI.
Industry payments across OH — which companies pay providers there.
